speckled ANA

The speckled pattern arises when autoantibodies target non-DNA nuclear antigens called extractable nuclear antigens (ENAs), which are soluble proteins complexed with RNA in the nucleoplasm. On indirect immunofluorescence using HEp-2 cells, these antibodies produce a granular or speckled fluorescence pattern across the nucleus, sparing the nucleoli and chromosomal regions during mitosis (distinguishing it from homogeneous or peripheral patterns associated with anti-dsDNA and anti-histone antibodies).

Key associations by specific antibody: - Anti-Sm (Smith antigen): Highly specific for SLE, associated with lupus nephritis - Anti-U1-RNP: Mixed connective tissue disease (MCTD); high titers can occur without other autoantibodies - Anti-SS-A/Ro and Anti-SS-B/La: Sjögren syndrome, also linked to neonatal lupus and congenital heart block in offspring of affected mothers; subacute cutaneous lupus - Anti-Scl-70 (topoisomerase I): Diffuse systemic sclerosis - Anti-centromere: Limited systemic sclerosis (CREST syndrome) - though this often produces a discrete speckled pattern

Clinical significance: A positive speckled ANA warrants reflex testing for specific ENA antibodies via ELISA or multiplex immunoassay to identify the underlying autoimmune condition. This pattern lacks diagnostic specificity on its own since it occurs in lupus, Sjögren syndrome, scleroderma, MCTD, and even in some healthy individuals (low titer). Clinical correlation with symptoms (malar rash, dry eyes/mouth, Raynaud phenomenon, skin thickening) and additional serologic workup are essential for diagnosis.

For boards: Remember that ANA screening is highly sensitive but not specific; a positive speckled pattern should prompt specific antibody testing (anti-Sm, anti-RNP, anti-Ro/La) to narrow the differential diagnosis among connective tissue diseases.